C1orf174

gene
On this page

Also known as RP13-531C17.2

Summary

C1orf174 (chromosome 1 open reading frame 174, HGNC:27915) is a protein-coding gene on chromosome 1p36.32, encoding UPF0688 protein C1orf174 (Q8IYL3).

Located in nucleoplasm.

Source: NCBI Gene 339448 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 18 total — 2 pathogenic
  • MANE Select transcript: NM_207356

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:27915
Approved symbolC1orf174
Namechromosome 1 open reading frame 174
Location1p36.32
Locus typegene with protein product
StatusApproved
AliasesRP13-531C17.2
Ensembl geneENSG00000198912
Ensembl biotypeprotein_coding
Entrez339448

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 5 nonsense_mediated_decay, 3 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000361605, ENST00000474140, ENST00000486765, ENST00000679703, ENST00000679929, ENST00000679946, ENST00000680054, ENST00000680169, ENST00000680279, ENST00000680535, ENST00000681823

RefSeq mRNA: 1 — MANE Select: NM_207356 NM_207356

CCDS: CCDS53

Canonical transcript exons

ENST00000361605 — 4 exons

ExonStartEnd
ENSE0000189134139001723900272
ENSE0000346637438905693891057
ENSE0000354880238928833892996
ENSE0000366545738891333890073

Expression profiles

Bgee: expression breadth ubiquitous, 281 present calls, max score 98.21.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 19.8755 / max 108.5483, expressed in 1813 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
996619.87551813

Top tissues by expression

286 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
oocyteCL:000002398.21gold quality
secondary oocyteCL:000065596.54gold quality
gingival epitheliumUBERON:000194989.91gold quality
skin of hipUBERON:000155489.87gold quality
blood vessel layerUBERON:000479788.81gold quality
nephron tubuleUBERON:000123188.78gold quality
hair follicleUBERON:000207388.25gold quality
granulocyteCL:000009488.04gold quality
upper leg skinUBERON:000426287.86gold quality
gingivaUBERON:000182887.83gold quality
mucosa of sigmoid colonUBERON:000499387.78gold quality
colonic mucosaUBERON:000031787.52gold quality
pylorusUBERON:000116687.19gold quality
urethraUBERON:000005787.15gold quality
seminal vesicleUBERON:000099887.09gold quality
saphenous veinUBERON:000731887.01gold quality
renal glomerulusUBERON:000007486.94gold quality
renal medullaUBERON:000036286.76gold quality
penisUBERON:000098986.65gold quality
synovial jointUBERON:000221786.63gold quality
right lobe of liverUBERON:000111486.55gold quality
superficial temporal arteryUBERON:000161486.55gold quality
spleenUBERON:000210686.51gold quality
lower esophagus mucosaUBERON:003583486.51gold quality
mucosa of transverse colonUBERON:000499186.39gold quality
metanephric glomerulusUBERON:000473686.37gold quality
duodenumUBERON:000211486.36gold quality
superior surface of tongueUBERON:000737186.33gold quality
oviduct epitheliumUBERON:000480486.31gold quality
lower esophagusUBERON:001347386.30gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes7.17

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

43 targeting C1orf174, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-4455100.0065.481587
HSA-MIR-548AW99.9972.573559
HSA-MIR-453199.9969.703181
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-314899.9775.066478
HSA-MIR-60799.9773.625593
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-365899.9673.874379
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-806399.9169.763146
HSA-MIR-130599.9171.433443
HSA-MIR-469899.8471.414303
HSA-MIR-808099.8267.521342
HSA-MIR-548AJ-5P99.7871.123085
HSA-MIR-548F-5P99.7871.023093
HSA-MIR-548G-5P99.7871.123085
HSA-MIR-548X-5P99.7871.123085
HSA-MIR-518A-5P99.7069.012209
HSA-MIR-52799.7069.012209
HSA-MIR-6892-3P99.6866.401178
HSA-MIR-64699.6867.841645
HSA-MIR-1251-3P99.6467.211408
HSA-MIR-445299.5068.451493
HSA-MIR-1213199.4868.721673
HSA-MIR-56999.4266.321009
HSA-MIR-4666A-5P99.4169.721887
HSA-MIR-29799.4069.581418
HSA-MIR-442699.1766.741949

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriosi:ch211-147a11.3ENSDARG00000069009
mus_musculusA430005L14RikENSMUSG00000047613
rattus_norvegicusC5h1orf174ENSRNOG00000025034

Protein

Protein identifiers

UPF0688 protein C1orf174Q8IYL3 (reviewed: Q8IYL3)

All UniProt accessions (7): Q8IYL3, A0A7P0T887, A0A7P0T8I3, A0A7P0T8M5, A0A7P0TAC3, A0A7P0TAV4, A0A7P0Z4H8

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Nucleus.

Similarity. Belongs to the UPF0688 family.

RefSeq proteins (1): NP_997239* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR031530UPF0688Family

Pfam: PF15772

UniProt features (10 total): sequence variant 3, region of interest 2, compositionally biased region 2, modified residue 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IYL3-F161.920.06

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 148, 189

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 119 (showing top): BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP, FISCHER_DREAM_TARGETS, HAN_SATB1_TARGETS_DN, MARSON_BOUND_BY_E2F4_UNSTIMULATED, MULLIGHAN_MLL_SIGNATURE_1_DN, chr1p36, JOHNSTONE_PARVB_TARGETS_3_DN, GCNP_SHH_UP_LATE.V1_UP, ATF5_TARGET_GENES, CIITA_TARGET_GENES, COBLL1_TARGET_GENES, E2F2_TARGET_GENES, E2F5_TARGET_GENES, HES2_TARGET_GENES, NFE2L1_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): nucleoplasm (GO:0005654), nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
nuclear lumen1
cellular anatomical structure1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

538 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
C1orf174CCDC27Q2M243575
C1orf174CEP104O60308506
C1orf174MRPS16Q9Y3D3494
C1orf174HAGHLQ6PII5447
C1orf174LRRC47Q8N1G4447
C1orf174PPP1R2CO14990393
C1orf174SPANXN1Q5VSR9390
C1orf174DENND10Q8TCE6379
C1orf174EFCAB14O75071377
C1orf174BRD10Q5HYC2374
C1orf174CXorf38Q8TB03370
C1orf174TPRG1LQ5T0D9370
C1orf174SPATA25Q9BR10370
C1orf174ARL16Q0P5N6357
C1orf174OSER1Q9NX31354

IntAct

47 interactions, top by confidence:

ABTypeScore
C1orf174PDIK1Lpsi-mi:“MI:0915”(physical association)0.900
PDIK1LCTDSPL2psi-mi:“MI:0914”(association)0.840
C1orf174IKZF1psi-mi:“MI:0915”(physical association)0.670
IKZF1C1orf174psi-mi:“MI:0915”(physical association)0.670
DCKDGUOKpsi-mi:“MI:0914”(association)0.620
IKZF1C1orf174psi-mi:“MI:0915”(physical association)0.560
MEOX2C1orf174psi-mi:“MI:0915”(physical association)0.560
STK35HSP90AA1psi-mi:“MI:0914”(association)0.530
C1orf174AHCYL1psi-mi:“MI:0914”(association)0.530
C1orf174TERF2IPpsi-mi:“MI:0915”(physical association)0.510
C1orf174SRPK2psi-mi:“MI:0217”(phosphorylation reaction)0.440
H3C1SMCHD1psi-mi:“MI:2364”(proximity)0.410
C1orf174MYH9psi-mi:“MI:0915”(physical association)0.400
Xpo1IFT56psi-mi:“MI:0914”(association)0.350
PDIK1LHSP90AA1psi-mi:“MI:0914”(association)0.350
STK35HSP90AA1psi-mi:“MI:0914”(association)0.350
PDIK1LCSTBpsi-mi:“MI:0914”(association)0.350
C1orf174H2AC11psi-mi:“MI:0914”(association)0.350
EGLN3KLK3psi-mi:“MI:0914”(association)0.350
C1orf174POLRMTpsi-mi:“MI:0914”(association)0.350

BioGRID (65): C1orf174 (Two-hybrid), C1orf174 (Two-hybrid), C1orf174 (Affinity Capture-MS), C1orf174 (Affinity Capture-MS), C1orf174 (Affinity Capture-MS), C1orf174 (Affinity Capture-MS), C1orf174 (Affinity Capture-MS), C1orf174 (Proximity Label-MS), C1orf174 (Affinity Capture-MS), C1orf174 (Two-hybrid), COPS6 (Two-hybrid), EEF1G (Two-hybrid), KAT5 (Two-hybrid), C1orf174 (Two-hybrid), C1orf174 (Two-hybrid)

ESM2 similar proteins: A0A087WXM9, A0A2K1JJ00, A0JM83, A4IGL8, E1BC15, E9Q5F9, O14513, O35923, O60673, O88491, P46013, P97929, Q14B71, Q28DZ0, Q29RT4, Q3MHH3, Q3TNU4, Q3ZBP0, Q4QY64, Q4V7J0, Q5DTT3, Q5E9A0, Q5F2C3, Q5RD08, Q5VWN6, Q5VYV7, Q61493, Q69YH5, Q6NS59, Q703I1, Q80U59, Q86XD8, Q8IXS0, Q8IYL3, Q8L7I1, Q8N7Z5, Q8NFU7, Q8TEP8, Q92628, Q96BU1

Diamond homologs: A0JM83, Q1L9C7, Q32PF7, Q3KQW6, Q5M951, Q80WR5, Q8IYL3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

18 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic2
Likely pathogenic0
Uncertain significance9
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (2)

Variant IDHGVSClassification
144175GRCh38/hg38 1p36.32(chr1:3712088-4027367)x4Pathogenic
974581Single allelePathogenic

SpliceAI

460 predictions. Top by Δscore:

VariantEffectΔscore
1:3890075:T:Cacceptor_gain1.0000
1:3900166:CCTCA:Cdonor_loss1.0000
1:3900167:CTCAC:Cdonor_loss1.0000
1:3900168:TCAC:Tdonor_loss1.0000
1:3900169:CACC:Cdonor_loss1.0000
1:3890073:CCT:Cacceptor_gain0.9900
1:3890078:G:GCacceptor_gain0.9900
1:3891053:GAAGT:Gacceptor_gain0.9900
1:3891058:C:CCacceptor_gain0.9900
1:3900174:T:TAdonor_gain0.9900
1:3890563:TCTTA:Tdonor_loss0.9800
1:3890564:CTTA:Cdonor_loss0.9800
1:3890565:TTA:Tdonor_loss0.9800
1:3890566:TACC:Tdonor_loss0.9800
1:3890568:C:Adonor_loss0.9800
1:3891056:GT:Gacceptor_gain0.9800
1:3891057:TCT:Tacceptor_loss0.9800
1:3900170:A:ACdonor_gain0.9800
1:3900170:ACCTT:Adonor_gain0.9800
1:3900171:C:CCdonor_gain0.9800
1:3900171:CCTT:Cdonor_gain0.9800
1:3900171:CCTTC:Cdonor_gain0.9800
1:3890072:TCC:Tacceptor_loss0.9700
1:3890073:CC:Cacceptor_loss0.9700
1:3890074:C:CCacceptor_gain0.9700
1:3890074:CTT:Cacceptor_loss0.9700
1:3890075:T:TCacceptor_gain0.9700
1:3890078:G:Cacceptor_gain0.9700
1:3891055:AGT:Aacceptor_gain0.9700
1:3892920:T:TAdonor_gain0.9700

AlphaMissense

1596 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:3890008:G:CF228L0.998
1:3890008:G:TF228L0.998
1:3890010:A:GF228L0.998
1:3890020:T:AR224S0.998
1:3890020:T:GR224S0.998
1:3890021:C:GR224T0.998
1:3890009:A:GF228S0.996
1:3890013:G:CH227D0.996
1:3890021:C:AR224I0.996
1:3890594:A:GF198S0.996
1:3890620:G:CS189R0.995
1:3890620:G:TS189R0.995
1:3890622:T:GS189R0.995
1:3890590:A:CF199L0.994
1:3890590:A:TF199L0.994
1:3890592:A:GF199L0.994
1:3890593:G:CF198L0.993
1:3890593:G:TF198L0.993
1:3890595:A:GF198L0.993
1:3890022:T:CR224G0.992
1:3890032:T:AR220S0.992
1:3890032:T:GR220S0.992
1:3890009:A:CF228C0.991
1:3890033:C:GR220T0.991
1:3890011:A:CH227Q0.988
1:3890011:A:TH227Q0.988
1:3890035:G:CS219R0.988
1:3890035:G:TS219R0.988
1:3890037:T:GS219R0.988
1:3889999:T:AK231N0.987

dbSNP variants (sampled 300 via entrez): RS1000177534 (1:3891773 T>A,C), RS1000256530 (1:3900384 G>C,T), RS1000329359 (1:3897389 A>G), RS1000386651 (1:3897049 G>A), RS1000543148 (1:3901240 C>A,T), RS1000998172 (1:3896751 T>C), RS1001133448 (1:3897008 T>C), RS1001236082 (1:3893412 A>T), RS1001388692 (1:3898202 T>C), RS1001949083 (1:3902177 C>A,T), RS1002172475 (1:3894707 T>C), RS1002374851 (1:3899547 C>T), RS1002525992 (1:3894030 A>G), RS1002631261 (1:3894424 A>G,T), RS1002952320 (1:3894242 T>A,C)

Disease associations

OMIM: gene `` | disease phenotypes: MIM:607872

GenCC curated gene-disease

Mondo (2): chromosome 1p36 deletion syndrome (MONDO:0011929), megacolon (MONDO:0001273)

Orphanet (1): 1p36 deletion syndrome (Orphanet:1606)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST002701_10Verbal declarative memory3.000000e-06
GCST002701_34Verbal declarative memory3.000000e-07
GCST002701_9Verbal declarative memory2.000000e-06

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004874memory performance
EFO:0006805word list delayed recall measurement

MeSH disease descriptors (2)

DescriptorNameTree numbers
D008531MegacolonC06.405.469.158.701
C535362Chromosome 1p36 Deletion Syndrome (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

27 total (human), top 27 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression, increases methylation4
sodium arsenitedecreases expression, increases abundance2
Arsenicaffects methylation, decreases expression, increases abundance2
GSK-J4increases expression1
coumarindecreases phosphorylation1
di-n-butylphosphoric acidaffects expression1
ICG 001increases expression1
abrinedecreases expression1
(+)-JQ1 compounddecreases expression1
Temozolomideincreases expression1
Sunitinibincreases expression1
Vorinostatincreases expression1
Leflunomidedecreases expression1
Air Pollutantsdecreases expression, increases abundance1
Caffeineincreases phosphorylation1
Diazinonincreases methylation1
Diurondecreases expression1
Enzyme Inhibitorsdecreases activity, increases O-linked glycosylation1
Formaldehydedecreases expression1
Ketoconazoleincreases expression1
Thimerosalincreases expression1
Thiramdecreases expression1
Tobacco Smoke Pollutiondecreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression1
Aflatoxin B1increases methylation1
Cadmium Chlorideincreases expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

4 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT01793168Not specifiedRECRUITINGRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
NCT02381457Not specifiedCOMPLETEDSNP-based Microdeletion and Aneuploidy RegisTry (SMART)
NCT04340856Not specifiedCOMPLETEDRetrospective, Uncontrolled Cohort Study on the Therapy of Chronic Megalon
NCT07470892Not specifiedNOT_YET_RECRUITINGPreoperative Fish Oil PN and Prognosis After Constipation Surgery